Synthetic Biologics (SYN) Reports In-Line Q1 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. USO
2. MRVL
3. SPY
4. BBIO
5. NVDA
6. GOOGL
7. OPCH
8. CHRW
9. AMD
10. HUBS

Go back to Synthetic Biologics (SYN) Reports In-Line Q1 EPS

Synthetic Biologics Reports First Quarter 2022 Operational Highlights and Financial Results

May 16, 2022 8:00 AM EDT

-Encouraging data further supports the development of novel oncolytic adenovirus (OV) platform; Announced a peer-reviewed publication highlighting positive clinical data on VCN-01 and an upcoming oral presentation on VCN-11, a novel oncolytic adenovirus designed to evade neutralizing antibodies-

- Reported positive safety data on SYN-020 intestinal alkaline phosphatase from the Phase 1 Multiple Ascending Dose clinical trial-

-Formed Scientific Advisory Board and strengthened the leadership team to support transformative clinical development strategy and extension into oncology -

-As of March 31, 2022, Synthetic... More